F3Logic’s Novavax NVAX Stock Holding History

F3Logic’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-617	Closed	-$7K	–	224
2019 Q1	$7K	Hold	617	–	–	﹤0.01%	209
2018 Q4	$23K	Hold	617	–	–	0.01%	162
2018 Q3	$23K	Hold	617	–	–	0.03%	78
2018 Q2	$17K	Hold	617	–	–	0.01%	103
2018 Q1	$26K	Buy	+617	New	+$24.8K	0.02%	106

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

F3Logic's NVAX Position: Q2 2019 in Review

F3Logic sold out of Novavax (NVAX) in Q2 2019, closing a stake of 617 shares — an estimated $7K sold.

F3Logic first reported a position in NVAX in Q1 2018 and held it in 5 quarters. The position peaked at $26K in Q1 2018. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

F3Logic reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
F3Logic sold 617 Novavax shares in Q2 2019, an estimated $7K.
F3Logic first reported a position in Novavax in Q1 2018 and held it in 5 quarters.
F3Logic's Novavax position peaked at $26K in Q1 2018.
81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on F3Logic's 13F filing for Q2 2019, filed 2 Aug 2019.